Pesquisas alternativas:
liver thle2 » liver three (Expandir a Pesquisa)
sleep ther » sleep theta (Expandir a Pesquisa), sleep where (Expandir a Pesquisa), sleep than (Expandir a Pesquisa)
does liver » does life (Expandir a Pesquisa), does laser (Expandir a Pesquisa), drives liver (Expandir a Pesquisa)
drug does » drug doses (Expandir a Pesquisa), drugs does (Expandir a Pesquisa), drug de (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
dose give » dose gives (Expandir a Pesquisa), dose live (Expandir a Pesquisa), doses given (Expandir a Pesquisa)
liver thle2 » liver three (Expandir a Pesquisa)
sleep ther » sleep theta (Expandir a Pesquisa), sleep where (Expandir a Pesquisa), sleep than (Expandir a Pesquisa)
does liver » does life (Expandir a Pesquisa), does laser (Expandir a Pesquisa), drives liver (Expandir a Pesquisa)
drug does » drug doses (Expandir a Pesquisa), drugs does (Expandir a Pesquisa), drug de (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
dose give » dose gives (Expandir a Pesquisa), dose live (Expandir a Pesquisa), doses given (Expandir a Pesquisa)
21
Por Yoshida, Naoko, Numano, Midori, Nagasaka, Yoko, Ueda, Kaori, Tsuboi, Hirohito, Tanimoto, Tsuyoshi, Kimura, Kazuko
Publicado no BMC Complement Altern Med (2015)
“...BACKGROUND: Weight-loss medicines, including crude drugs and herbal supplements disguised as diet...”Publicado no BMC Complement Altern Med (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
22
“... literature supports that TRT does not substantially worsen lower urinary tract symptoms, and may actually...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
23
“... using plethysmography. Coadministration of 2.0 g/kg ethanol i.v. with 600 mg/kg GHB i.v. increased sleep...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
24
Por Gouws, Eleanor, Bryce, Jennifer, Habicht, Jean-Pierre, Amaral, João, Pariyo, George, Schellenberg, Joanna Armstrong, Fontaine, Olivier
Publicado em 2004
“...-survival intervention. Ensuring that children younger than five who need these drugs receive them promptly...”Publicado em 2004
Obter o texto integral
Obter o texto integral
Artigo
25
Por Qatmosh, Sandra A., Koni, Amer A., Qeeno, Baraa G., Arandy, Dina A., Abu-Hashia, Maysa W., Al-hroub, Bahaa M., Zyoud, Sa’ed H.
Publicado no BMC Public Health (2017)
“... of them included the brand name, active ingredients, indications, directions for use, adverse drug...”Publicado no BMC Public Health (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
26
Por Zhou, Meiling, Hou, Jierong, Zhong, Zhirong, Hao, Na, Lin, Yan, Li, Chunhong
Publicado no Drug Deliv (2018)
“...Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disease. Long-term, high-dose...”Publicado no Drug Deliv (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
27
“.... The anaesthetic Saffan also enhanced drug cell kill; the largest Dose Modifying Factor (2.7) was measured...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
28
“..., because it may reversibly bind to melanin, leading to prolonged drug exposure, was examined. Clonal lines...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
29
Por Konta, Andrea Alice, García-Piña, Marta, Serrano, Dolores R.
Publicado no Bioengineering (Basel) (2017)
“... different backgrounds with diverse customs, metabolism, and necessities. Dose adjustment is frequently based...”Publicado no Bioengineering (Basel) (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
30
“... that they shook the suspension bottle before use. Regarding dose administration, 313 (78.2 %) considered syringe...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
31
Por Darnaud, Léa, Lamoureux, Fabien, Godet, Cendrine, Pontier, Sandrine, Debard, Alexia, Venisse, Nicolas, Martins, Pauline, Concordet, Didier, Gandia, Peggy
Publicado no Drugs R D (2018)
“... interactions or cytochrome P450 3A4/5 polymorphisms. For two of them, a drug dosage adjustment was proposed...”Publicado no Drugs R D (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
32
Por Ochab, Magdalena, Puszynski, Krzysztof, Swierniak, Andrzej
Publicado no Biomed Eng Online (2017)
“...BACKGROUND: Examination of physiological processes and the influences of the drugs on them can...”Publicado no Biomed Eng Online (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
33
Por Lenander, Cecilia, Bondesson, Åsa, Viberg, Nina, Beckman, Anders, Midlöv, Patrik
Publicado no BMC Health Serv Res (2018)
“...–35) and 61% of them used 10 drugs or more. Of the patients, 84% had at least one DRP with a mean...”Publicado no BMC Health Serv Res (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
34
“... factor receptor 2-negative advanced breast cancer significantly. To date, three CDK4/6 inhibitors...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
35
Por Denekamp, J., Michael, B. D., Minchinton, A. I., Smithen, C. E., Stewart, F. A., Stratford, M. R., Terry, N. H.
Publicado em 1982
“... skin was made acutely hypoxic for the irradiations, to give radioprotection by a factor of 2.7-3.0...”Publicado em 1982
Obter o texto integral
Obter o texto integral
Artigo
36
“..., authenticated, and processed as per classics to get Churna and Vati. Test drugs were administered in the dose...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
37
Por Millán Núñez-Cortés, Jesús, Cases Amenós, Aleix, Ascaso Gimilio, Juan Francisco, Barrios Alonso, Vivencio, Pascual Fuster, Vicente, Pedro-Botet Montoya, Juan Carles, Pintó Sala, Xavier, Serrano Cumplido, Adalberto
Publicado no Am J Cardiovasc Drugs (2016)
“... factors are the drug characteristics (potency, dose), patient characteristics (kidney function, age...”Publicado no Am J Cardiovasc Drugs (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
38
“... at a dose of 20 mg/kg. Synergistic treatment of salirasib and Exo2 exhibits a superior inhibitory...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
39
“..., and the only 2 patients received normal dose of streptomycin. (2) The pharmacokinetic behaviors of streptomycin...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
40
Por Yakoot, Mostafa
Publicado em 2012
“..., the enrollment criteria, the methodology, the dose of the studied drug and all the combined medications...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo